Approval is based on data from two Phase III studies in branch and central retinal vein occlusion (RVO) showing early and sustained vision improvements non-inferior to aflibercept
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret
Acquisition includes Restoret, a novel late-phase candidate for diabetic macular edema and neovascular age-related macular degeneration
Vision loss due to Glaucoma can be prevented if it is detected and treated early
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
73% have cited fears like losing eyesight, painful procedure or long recovery period when it comes to cataract surgeries
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma
Subscribe To Our Newsletter & Stay Updated
